Elotuzumab is a speciality medication used in the management of Multiple Myeloma, a Haematological disorder. This drug has been given the breakthrough therapy status by the US FDA. Such designated drugs have significant role in the treatment of rare diseases and advanced conditions. Empliciti is the trade or brand name of this medication which is available as Empliciti 300mg and Empliciti 400mg. In Europe and US, this drug is commercially available, which is not the case in India. Therefore Elotuzumab in India is imported based on specific patient needs.
Empliciti was developed by Bristol-Myers Squibb and AbbVie, and is now commercially promoted by Bristol-Myers Squibb. The import possibilities for Empliciti in India are fulfilled from European countries like Germany. Going by the FDA approved indications, this drug is prescribed for Multiple Myeloma patients who have relapsed, those who underwent a prior treatment. In such cases, drugs like these are known to provide better outcomes and therefore it is always a genuine concern for the patients in India to seek import options.
Like many other chemotherapy or Haematology medications, Empliciti is a combination drug. The other medications that are to be given along with this drug are lenalidomide and dexamethasone. These two agents are available in India. There is another medication called Pomalyst, which can be offered instead of dexamethasone. Pomalyst is an option to import along with Empliciti in India.
Specialized medications eligible for Named Patient Import are to be recommended by the treating physicians through certified prescriptions. You can request your Haematologist to share his or her prescription as per the complete dosage planned for the therapy. You can then proceed to request for the Import Permit.
Import Permits in the name of specific patients are given by the Indian authorities. These are meant for the import of lifesaving drugs in limited quantities. There is a central government portal, managed by Central Drugs Standard Control Organisation. You can conveniently apply for the licenses digitally.
You must be aware that the Elotuzumab India legal import will be a time consuming process. For that reason, it is a wise thing to contact your trusted global source and initiate financial procedures through your bank at the earliest. Your supplier will help you with timelines, forecast, sourcing and shipment of the drug.
Once you initiate the procurement process, you need to simultaneously prepare the documents for the customs clearance of Empliciti in India. This saves your time and reduces stress in a lot many ways.
Depending on your arrangement with your preferred vendor, you can have the medicine delivered to your Hospital or any other location in India in ideal storage conditions.
1. You must be cautious in initiating the payment for vendors whom you find online without proper verification of their credentials. It is important for you to know of their experience in shipping drugs like Elotuzumab in India. You can very well ask them for documents to substantiate their claims.
2. Going by your treating physician’s recommendation is always an ideal thing to do. But, you must also assure yourself about the right cost. Sometimes you may receive very low price quotes, check for any compromise in such cases.
3. Your vendor or supplier must provide you with all the legal documents only on the name of patient. You must ensure commercial invoice and customs Bill of Entry copies are submitted to you for verification.
Synergy Drugs has the know-how about how Named Patient Services are operated in India. Our team can be approached for more information and assistance. You can be sure of gathering comprehensive information regarding the import of Elotuzumab in India. We will put you across the right procedures and sources that you can trust for sure.